U.S. screening recommendations now agree on starting mammography at age 40, but major organizations still differ on screening interval and when to stop. Here is what breast imaging professionals need to know in 2026….
CMS is adding two postprocedural breast diagnoses to its mammography coverage coding. Breast-imaging and revenue-cycle teams should prepare now for the codes and their separate effective dates….
Newly cleared AI software can detect and quantify breast arterial calcification on mammograms. The technology may support cardiovascular-risk conversations, but practices need clear reporting and referral pathways….
FDA has proposed moving digital breast tomosynthesis systems from Class III to Class II. Here is what the change could mean for manufacturers and mammography facilities—and what would remain unchanged….
FDA’s latest MQSA scorecard shows DBT at nearly 95% of certified mammography facilities, more than 44.8 million annual procedures and strong inspection compliance nationwide….